SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001157523-14-000880
Filing Date
2014-02-28
Accepted
2014-02-27 21:07:07
Documents
11
Period of Report
2014-02-27
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 OPEXA THERAPEUTICS, INC. 8-K a50814168.htm 8-K 17129
2 EXHIBIT 99.1 a50814168ex99_1.htm EX-99.1 14209
3 SLIDE 1 slide1.jpg GRAPHIC 208009
4 SLIDE 2 slide2.jpg GRAPHIC 474475
5 SLIDE 3 slide3.jpg GRAPHIC 147673
6 SLIDE 4 slide4.jpg GRAPHIC 340943
7 SLIDE 5 slide5.jpg GRAPHIC 262717
8 SLIDE 6 slide6.jpg GRAPHIC 234834
9 SLIDE 7 slide7.jpg GRAPHIC 274033
10 SLIDE 8 slide8.jpg GRAPHIC 251117
11 SLIDE 9 slide9.jpg GRAPHIC 253345
  Complete submission text file 0001157523-14-000880.txt   3405587
Mailing Address 2635 TECHNOLOGY FOREST BLVD. THE WOODLANDS TX 77381
Business Address 2635 TECHNOLOGY FOREST BLVD. THE WOODLANDS TX 77381 (281) 272-9331
Opexa Therapeutics, Inc. (Filer) CIK: 0001069308 (see all company filings)

IRS No.: 760333165 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33004 | Film No.: 14651207
SIC: 2834 Pharmaceutical Preparations